The GMO Emerging Country Debt UCITS Fund’s objective is total return in excess of that of its benchmark, the J.P. Morgan Emerging Markets Bond Global Diversified Index (EMBIG-D). The Fund invests primarily in external debt of sovereigns and quasi-sovereigns.
GMO’s Emerging Country Debt team focuses on bottom-up issue selection, seeking to find issues with similar default characteristics but better long-term total return potential than the issues in EMBIG-D. We believe that our approach provides long-term, value-oriented clients with the best chance for total return in this asset class and differentiates us from other emerging debt managers who focus on economic forecasting, market timing, and other macro/top-down approaches.
|Prospectus - Fifth Supplement||Download|
|Prospectus - First Supplement||Download|
|Prospectus - Fourth Supplement||Download|
|Prospectus - Second Supplement||Download|
|Prospectus – Singapore Wrapper March 2022||Download|
|Prospectus - Third Supplement||Download|
|Prospectus - UK Supplement||Download|
|KIIDs - GBP||Download|
|KIIDs - USD||Download|
|PRIIP - CHF||Download|
|PRIIP - EUR||Download|
|PRIIP - GBP||Download|
|PRIIP - USD||Download|
Commentary & Attribution
Risks associated with investing in the Fund may include: Credit Risk, Market Risk - Fixed Income, Illiquidity Risk, Derivatives and Short Sales Risk, and Counterparty Risk. For a more complete discussion of these risks and others, please consult the Fund's prospectus.
The making available of any document on this website does not constitute a promotion, offer or sale of any securities, financial instruments, or other financial products to the public in or into any jurisdiction where such promotion, offer or sale is prohibited or to any person or class of person to whom such securities or financial instruments may not be lawfully promoted, offered or sold. You should not rely on any document on this website in making any decision to engage in investment activity without seeking further information from GMO to enable GMO to determine whether you may be eligible to receive such further information or purchase or subscribe for any securities or other financial instruments.